Objective:Health: - Molnupiravir: Merck's New Anti-Covid Medication is Worse Than You Thought
November 16, 202121m 3s
Audio is streamed directly from the publisher (media.sott.net) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Last month pharmaceutical giant Merck has submitted their new drug Molnupiravir to the FDA for emergency approval 'because Covid'. Most people thought this would be an ivermectin knock-off that would get approved and get all the glory ivermectin should have been getting all along. But it's not that. It's worse. Much worse. Far from being a simple anti-viral like its predecessors, Molnupiravir works by incorporating itself into the genetic material of viruses, and then causing a huge number...